Total Payments
$241,005
2024 Payments
$66,372
Companies
58
Transactions
703
Medicare Patients
4,070
Medicare Billing
$373,362
Payment Breakdown by Category
Other$197,240 (81.8%)
Travel$21,832 (9.1%)
Food & Beverage$19,816 (8.2%)
Consulting$2,000 (0.8%)
Education$117.42 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $181,040 | 46 | 75.1% |
| Travel and Lodging | $21,832 | 54 | 9.1% |
| Food and Beverage | $19,816 | 595 | 8.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $16,200 | 5 | 6.7% |
| Consulting Fee | $2,000 | 1 | 0.8% |
| Education | $117.42 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $106,507 | 247 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $104,861 | 66 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $9,362 | 40 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $9,186 | 16 | $0 (2017) |
| CSA Medical, Inc | $2,903 | 4 | $0 (2019) |
| Boston Scientific Corporation | $1,112 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,104 | 47 | $0 (2024) |
| PFIZER INC. | $875.40 | 39 | $0 (2024) |
| Janssen Biotech, Inc. | $706.20 | 35 | $0 (2024) |
| GENZYME CORPORATION | $462.76 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66,372 | 127 | Regeneron Healthcare Solutions, Inc. ($51,363) |
| 2023 | $60,574 | 121 | Regeneron Healthcare Solutions, Inc. ($53,235) |
| 2022 | $13,433 | 107 | ABBVIE INC. ($12,011) |
| 2021 | $26,802 | 69 | AbbVie Inc. ($26,245) |
| 2020 | $345.47 | 14 | Janssen Scientific Affairs, LLC ($124.99) |
| 2019 | $15,388 | 75 | AbbVie, Inc. ($12,038) |
| 2018 | $23,706 | 83 | AbbVie, Inc. ($13,927) |
| 2017 | $34,385 | 107 | AbbVie, Inc. ($23,568) |
All Payment Transactions
703 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.75 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Boston Scientific Corporation | Acquire (Device) | Food and Beverage | In-kind items and services | $47.37 | General |
| Category: Acquire_ENDO | ||||||
| 12/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: IMMUNOLOGY | ||||||
| 12/08/2024 | STERIS CORPORATION | — | Food and Beverage | In-kind items and services | $71.40 | General |
| 12/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $117.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Boston Scientific Corporation | Axios (Device) | Food and Beverage | In-kind items and services | $172.90 | General |
| Category: Axios_ENDO | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/31/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $34.67 | General |
| Category: GI | ||||||
| 10/27/2024 | STERIS CORPORATION | truFreeze (Device), Padlock Clip | Food and Beverage | In-kind items and services | $141.55 | General |
| Category: Gastroenterology | ||||||
| 10/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $81.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $45.35 | General |
| Category: TheraSphere_PI | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.19 | General |
| Category: Immunology | ||||||
| 10/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/15/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | STERIS CORPORATION | truFreeze (Device) | Food and Beverage | In-kind items and services | $96.49 | General |
| Category: Gastroenterology | ||||||
| 10/07/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,112 | 1,179 | $1.2M | $103,544 |
| 2022 | 18 | 1,104 | 1,168 | $1.3M | $97,176 |
| 2021 | 14 | 933 | 1,002 | $993,924 | $87,359 |
| 2020 | 19 | 921 | 1,009 | $886,022 | $85,283 |
Total Patients
4,070
Total Services
4,358
Medicare Billing
$373,362
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 140 | 140 | $257,564 | $28,346 | 11.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 163 | 193 | $67,608 | $19,258 | 28.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 160 | 160 | $286,211 | $9,825 | 3.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $27,173 | $7,524 | 27.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 137 | 146 | $230,794 | $6,903 | 3.0% |
| 43274 | Insertion of stent into pancreatic or bile duct using a flexible endoscope | Facility | 2023 | 12 | 18 | $30,825 | $5,543 | 18.0% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 27 | 29 | $24,309 | $4,979 | 20.5% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 20 | $19,520 | $3,751 | 19.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 36 | 38 | $179,808 | $3,383 | 1.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 25 | 25 | $8,859 | $2,674 | 30.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $9,461 | $2,525 | 26.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 33 | $6,180 | $2,082 | 33.7% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 14 | 17 | $22,923 | $1,881 | 8.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 26 | $6,460 | $1,853 | 28.7% |
| 43262 | Incision of pancreatic outlet using a flexible endoscope | Facility | 2023 | 12 | 12 | $15,901 | $1,124 | 7.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $17,215 | $916.82 | 5.3% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 195 | 196 | $32,468 | $872.52 | 2.7% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 21 | 21 | $517.44 | $104.04 | 20.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 115 | 117 | $214,956 | $22,877 | 10.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 179 | $62,711 | $17,983 | 28.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 132 | 132 | $236,042 | $10,253 | 4.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 173 | 180 | $284,080 | $9,283 | 3.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 59 | 59 | $26,710 | $7,833 | 29.3% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 50 | 57 | $269,919 | $4,910 | 1.8% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 28 | 28 | $23,471 | $4,085 | 17.4% |
About Dr. Walter Coyle, M.D
Dr. Walter Coyle, M.D is a Gastroenterology healthcare provider based in La Jolla, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609847482.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Walter Coyle, M.D has received a total of $241,005 in payments from pharmaceutical and medical device companies, with $66,372 received in 2024. These payments were reported across 703 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($181,040).
As a Medicare-enrolled provider, Coyle has provided services to 4,070 Medicare beneficiaries, totaling 4,358 services with total Medicare billing of $373,362. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Internal Medicine
- Location La Jolla, CA
- Active Since 01/30/2006
- Last Updated 02/16/2017
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1609847482
Products in Payments
- DUPIXENT (Biological) $88,925
- CREON (Drug) $48,756
- XIFAXAN (Drug) $18,445
- Creon (Drug) $13,289
- LINZESS (Drug) $950.82
- XELJANZ (Drug) $861.89
- ENTYVIO (Biological) $703.44
- STELARA (Biological) $644.59
- Humira (Biological) $404.25
- RINVOQ (Biological) $396.36
- Cimzia (Drug) $324.45
- HUMIRA (Biological) $314.89
- DIFICID (Drug) $308.68
- GATTEX (Drug) $295.92
- SKYRIZI (Biological) $289.06
- truFreeze (Device) $238.04
- Entyvio (Biological) $227.31
- CLENPIQ (Drug) $212.89
- MAVYRET (Drug) $210.64
- OCALIVA (Drug) $208.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in La Jolla
Dr. Catherine Frenette, M.d, M.D
Gastroenterology — Payments: $672,212
Gastroenterology $672,212
Dr. Quan Nhu, M.d., Ph.d, M.D., PH.D
Gastroenterology — Payments: $498,895
Gastroenterology $498,895
Dr. Paul Pockros, M.d, M.D
Gastroenterology — Payments: $478,769
Gastroenterology $478,769
Dr. Adam Deising, D.o, D.O
Gastroenterology — Payments: $86,643
Gastroenterology $86,643
Dr. Sushrut Thiruvengadam, M.d, M.D
Gastroenterology — Payments: $51,904
Gastroenterology $51,904
Syed Fehmi, M.d., M.s, M.D., M.S
Gastroenterology — Payments: $19,681
Gastroenterology $19,681